tipranavir
Tipranavir is a protease inhibitor used in the treatment of HIV-1 infection. It is a non-peptide protease inhibitor that is typically prescribed in combination with ritonavir to boost its plasma levels, forming a boosted regimen known as tipranavir/ritonavir. It is primarily indicated for treatment-experienced adults and, in some settings, pediatric patients who have limited options due to resistance to other antiretroviral drugs.
Tipranavir works by inhibiting the HIV-1 protease enzyme, which is essential for the maturation of infectious
Administration and pharmacology notes: boosted tipranavir/ritonavir is administered twice daily, with dosing adjusted for aspects such
Safety and adverse effects: tipranavir/ritonavir has been associated with hepatotoxicity and pancreatitis, as well as lipid